Journey to EU projects - matchmaking session

13 May 2025 | Warsaw, Poland

HomeParticipantsProject ideas & expertiseAgendaHelp

Robert Lugowski

CEO

CliniNote

1 profile visitParticipant

CEO @CliniNote: Driving Innovation in Clinical Trials & Real-World Data | Passionate Advocate for Digital Health & HealthTech Startups

My organisation

CliniNote

CliniNote

Start-up

Warsaw, Poland

CliniNote is pioneering a new category of AI/NLP-powered tools that radically improve the efficiency and quality of data capture in healthcare, eg streamlining clinical trials or real-world evidence collection.
Read more

About me

Skills

  • healthcare data
  • clinical trials
  • Real-World Evidence
  • RWD

Interests

  • Healthcare Innovation

Additional questions

Areas of interest

Cluster 1:Destination - Staying healthy in a rapidly changing society Cluster 1: Destination - Living and working in a health-promoting environment Cluster 1: Destination - Ensuring equal access to innovative, sustainable, and high-quality healthcare Cluster 1: Destination - Developing and using new tools, technologies and digital solutions for a healthy societyCluster 1: Destination - Maintaining an innovative, sustainable, and competitive EU health industry

Participant's current Engagement in EU projects

Consortium leader searching for partnersProject idea under development Project participant searching for consortia

Marketplace (2)

  • Project cooperation

    ACRE AI

    Advancing Clinical Research in Europe with AI-powered Data Framework (ACRE AI)

    • Partner seeks Consortium/Coordinator
    • Consortium/Coordinator seeks Partners
    • HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies
    • Cluster Food (CL6): HORIZON-CL6-2025-02-FARM2FORK-12 Nutrition and Mental Health
    • HORIZON-CL4-2025-03-HUMAN-18: GenAI4EU central Hub (CSA) (AI/Data/Robotics Partnership)
    • HORIZON-HLTH-2025-03-TOOL-01-two-stage: Enhancing cell therapies with genomic techniques
    • HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)
    • HORIZON-CL4-2025-04-DATA-03: Software Engineering for AI and generative AI (RIA) (AI/Data/Robotics Partnership)
    • HORIZON-CL4-2025-04-DIGITAL-EMERGING-06: Challenge-Driven GenAI4EU Booster (RIA) (AI/Data/Robotics Partnership)
    • HORIZON-CL4-2025-03-DATA-13: Fostering Innovative and Compliant Data Ecosystems (IA) (AI, Data and Robotics Partnership)
    • Cluster Health (CL1): HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response
    • HORIZON-CL4-2025-04-DATA-02: Empowering AI/generative AI along the Cognitive Computing continuum (RIA) (AI/Data/Robotics Partnership)
    • HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health
    • Cluster Health (CL1): HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families
    • HORIZON-HLTH-2025-01-IND-03: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices
    • Cancer Mission: HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
    • HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential
    • HORIZON-HLTH-2025-01-DISEASE-01: Randomised controlled trials to test safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
    • Cluster Health (CL1): HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)
    • HORIZON-HLTH-2025-03-DISEASE-06-two-stage: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)

    Robert Lugowski

    CEO at CliniNote